CRON
Cronos Group Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.26
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- 59.27x
- P/E 2026E
- 20.67x
- P/E 2027E
- 28.72x
- P/E 2028E
- 24.70x
- P/S forward
- 5.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.98x
- PEG TTM
- —
- Price / book
- 1.12x
- Price / sales
- 4.95x
- Price / cash flow
- 21.87x
Enterprise value
- Enterprise value
- $454.1M
- EV / sales
- 1.87x
- EV / EBITDA
- 18.64x
- EV / EBIT
- 36.51x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026